Eric M. Dube - 06 Jun 2023 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Director
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
06 Jun 2023
Net transactions value
$0
Form type
4
Filing time
08 Jun 2023, 18:02:20 UTC
Previous filing
02 Feb 2023
Next filing
05 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock Option (right to buy) Award $0 +17,500 $0.000000 17,500 06 Jun 2023 Common Stock 17,500 $9.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest on the earlier of June 6, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.